Search

Your search keyword '"Silicosis blood"' showing total 35 results

Search Constraints

Start Over You searched for: Descriptor "Silicosis blood" Remove constraint Descriptor: "Silicosis blood" Search Limiters Full Text Remove constraint Search Limiters: Full Text
35 results on '"Silicosis blood"'

Search Results

1. Exosomal proteomics and cytokine analysis distinguish silicosis cases from controls.

2. Clinical usefulness of serum angiotensin converting enzyme in silicosis.

3. Analysis of Immune Cell Subsets in Peripheral Blood from Patients with Engineered Stone Silica-Induced Lung Inflammation.

4. Influence of Silica Exposure for Lung Silicosis Rat.

5. A rapid point of care CC16 kit for screening of occupational silica dust exposed workers for early detection of silicosis/silico-tuberculosis.

6. Serum levels of inflammatory mediators as prognostic biomarker in silica exposed workers.

7. Distinct metabolic features in the plasma of patients with silicosis and dust-exposed workers in China: a case-control study.

8. Decreased Soluble Receptor of Advanced Glycation End Product Levels Correlated with Inflammation in Silicosis.

9. Role of Nephronectin in Pathophysiology of Silicosis.

10. CD3 + , CD4 + , and CD8 + Expression in Cells in Peripheral Blood of Silicosis Patients and Intervention Effect of Thymalfasin.

12. Association between Plasma HMGB-1 and Silicosis: A Case-Control Study.

13. Silicosis and Silica-Induced Autoimmunity in the Diversity Outbred Mouse.

14. circRNA Mediates Silica-Induced Macrophage Activation Via HECTD1/ZC3H12A-Dependent Ubiquitination.

15. Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.

16. Treatment of silicosis with hepatocyte growth factor-modified autologous bone marrow stromal cells: a non-randomized study with follow-up.

17. Silica exposure and altered regulation of autoimmunity.

18. Role of Fas/FasL pathway-mediated alveolar macrophages releasing inflammatory cytokines in human silicosis.

19. Assessment of serum antioxidant status in patients with silicosis.

20. Angiogenic activity of sera from silicosis and pulmonary Langerhans cell histiocytosis patients in relation to lung function tests.

21. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.

22. Interleukin-12B-3'UTR polymorphism in association with IL-12p40 and IL-12p70 serum levels and silicosis severity.

23. Cell markers, cytokines, and immune parameters in cement mason apprentices.

24. Lymphopenia in occupational pulmonary silicosis with or without autoimmune disease.

25. Serum levels of soluble Fas ligand in patients with silicosis.

26. Evaluation of cases with silicosis using the parameters related to Fas-mediated apoptosis.

27. Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours.

28. Serum lactate dehydrogenase and its isoenzyme pattern in ex-coalminers.

29. Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity.

30. Studies on production of anticollagen antibodies in silicosis.

32. Role of family susceptibility, occupational and family histories and individuals' blood groups in the development of silicosis.

34. Relationship between silicosis and rheumatoid arthritis.

Catalog

Books, media, physical & digital resources